Europe Medical Polyoxymethylene (pom) Market Size & Outlook
Europe medical polyoxymethylene (pom) market, 2018-2030 (US$M)
Related Markets
Europe medical polyoxymethylene (pom) market highlights
- The Europe medical polyoxymethylene (pom) market generated a revenue of USD 23.1 million in 2023.
- The market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, copolymer pom was the largest revenue generating type in 2023.
- Copolymer POM is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 23.1 million |
| Market revenue in 2030 | USD 35.5 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Copolymer pom |
| Fastest growing segment | Copolymer POM |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Homopolymer POM, Copolymer POM |
| Key market players worldwide | Dow Inc, Celanese Corp Class A, DuPont de Nemours Inc, Daicel Corp, Asahi Kasei Corp, Mitsubishi Gas Chemical Co Inc, SABIC, Avient Corp, Clariant AG, Jet-Hot, Innovative Plastics, Korea Engineering Plastics Co., China National Bluestar Group, ICD High Performance Coatings |
Other key industry trends
- In terms of revenue, Europe region accounted for 19.7% of the global medical polyoxymethylene (pom) market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 69.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Polyoxymethylene (POM) Market Scope
Medical Polyoxymethylene (POM) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe medical polyoxymethylene (pom) market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical polyoxymethylene (pom) market will help companies and investors design strategic landscapes.
Copolymer pom was the largest segment with a revenue share of 63.2% in 2023. Horizon Databook has segmented the Europe medical polyoxymethylene (pom) market based on homopolymer pom, copolymer pom covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is a major industrial hub with extensive manufacturing capacity. The region is prosperous and has high income levels, which results into high expenditure on Healthcare. The region is home to numerous medical device manufacturing firms, making it an important market for medical-grade POMs.
According to Med Tech Europe, in 2023, the region accounted for a total of 35,000 medical technology firms, with 92% of them being small and medium sized enterprises. Since 26 May 2021, the medical device sector in Europe has been regulated Regulation 2017/745/EU.
Reasons to subscribe to Europe medical polyoxymethylene (pom) market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe medical polyoxymethylene (pom) market databook
-
Our clientele includes a mix of medical polyoxymethylene (pom) market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe medical polyoxymethylene (pom) market , including forecasts for subscribers. This continent databook contains high-level insights into Europe medical polyoxymethylene (pom) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe medical polyoxymethylene (pom) market size, by country, 2018-2030 (US$M)
Europe Medical Polyoxymethylene (POM) Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
